Deutsche Bank Ag\ Collegium Pharmaceutical, Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 74,999 shares of COLL stock, worth $2.25 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

74,999

Previous 70,667 6.13%

Holding current value

$2.25 Million

Previous $2.28 Million 27.34%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$31.4 - $39.07 $136,024 - $169,251	4,332 Added 6.13%	74,999 $2.9 Million
Q2 2024 Aug 14, 2024	SELL	$31.36 - $39.99 $69,744 - $88,937	-2,224 Reduced 3.05%	70,667 $2.28 Million
Q1 2024 May 15, 2024	BUY	$31.23 - $40.91 $1.68 Million - $2.19 Million	53,644 Added 278.71%	72,891 $2.83 Million
Q4 2023 Feb 14, 2024	SELL	$21.16 - $30.8 $8,167 - $11,888	-386 Reduced 1.97%	19,247 $592,000
Q3 2023 Nov 09, 2023	BUY	$21.23 - $24.28 $47,703 - $54,557	2,247 Added 12.92%	19,633 $438,000
Q2 2023 Aug 14, 2023	SELL	$21.06 - $24.0 $162,035 - $184,656	-7,694 Reduced 30.68%	17,386 $373,000
Q1 2023 May 15, 2023	BUY	$23.0 - $29.88 $200,905 - $261,001	8,735 Added 53.44%	25,080 $601,000
Q4 2022 Feb 13, 2023	BUY	$16.14 - $23.55 $4,761 - $6,947	295 Added 1.84%	16,345 $379,000
Q3 2022 Nov 14, 2022	SELL	$15.46 - $20.1 $34,444 - $44,782	-2,228 Reduced 12.19%	16,050 $257,000
Q2 2022 Aug 11, 2022	SELL	$14.22 - $20.88 $33,985 - $49,903	-2,390 Reduced 11.56%	18,278 $324,000
Q1 2022 May 13, 2022	SELL	$17.2 - $22.5 $35,586 - $46,552	-2,069 Reduced 9.1%	20,668 $421,000
Q4 2021 Feb 11, 2022	BUY	$17.5 - $21.35 $5,407 - $6,597	309 Added 1.38%	22,737 $425,000
Q3 2021 Nov 04, 2021	SELL	$17.75 - $25.39 $3.83 Million - $5.48 Million	-215,824 Reduced 90.59%	22,428 $443,000
Q2 2021 Aug 11, 2021	BUY	$21.74 - $25.28 $3.54 Million - $4.12 Million	163,014 Added 216.66%	238,252 $5.63 Million
Q1 2021 May 13, 2021	BUY	$19.25 - $26.1 $952,374 - $1.29 Million	49,474 Added 192.03%	75,238 $1.78 Million
Q4 2020 Feb 16, 2021	SELL	$17.83 - $22.29 $147,899 - $184,895	-8,295 Reduced 24.35%	25,764 $516,000
Q3 2020 Nov 12, 2020	SELL	$15.78 - $20.82 $656,448 - $866,112	-41,600 Reduced 54.98%	34,059 $708,000
Q2 2020 Aug 13, 2020	BUY	$15.49 - $23.51 $754,595 - $1.15 Million	48,715 Added 180.8%	75,659 $1.33 Million
Q1 2020 May 14, 2020	SELL	$13.89 - $25.45 $1.47 Million - $2.68 Million	-105,480 Reduced 79.65%	26,944 $440,000
Q4 2019 Feb 14, 2020	SELL	$10.7 - $22.24 $337,895 - $702,316	-31,579 Reduced 19.26%	132,424 $2.72 Million
Q3 2019 Nov 14, 2019	SELL	$10.16 - $13.28 $282,793 - $369,635	-27,834 Reduced 14.51%	164,003 $1.88 Million
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $1.67 Million - $2.61 Million	157,323 Added 455.82%	191,837 $2.52 Million
Q1 2019 May 15, 2019	SELL	$13.58 - $18.72 $105,435 - $145,342	-7,764 Reduced 18.36%	34,514 $520,000
Q4 2018 Feb 14, 2019	SELL	$14.78 - $19.68 $519,768 - $692,086	-35,167 Reduced 45.41%	42,278 $725,000
Q3 2018 Dec 21, 2021	BUY	$14.16 - $24.3 $176,872 - $303,531	12,491 Added 19.23%	77,445 $1.14 Million
Q3 2018 Nov 14, 2018	SELL	$14.16 - $24.3 $1.66 Million - $2.85 Million	-117,177 Reduced 64.34%	64,954 $956,000
Q2 2018 Apr 21, 2020	BUY	$21.79 - $28.29 $323,516 - $420,021	14,847 Added 8.88%	182,131 $4.34 Million
Q2 2018 Aug 14, 2018	SELL	$21.79 - $28.29 $3.68 Million - $4.78 Million	-169,073 Reduced 50.27%	167,284 $3.99 Million
Q1 2018 Oct 18, 2019	BUY	$18.15 - $29.21 $241,068 - $387,967	13,282 Added 4.11%	336,357 $8.59 Million
Q1 2018 May 15, 2018	SELL	$18.15 - $29.21 $1.65 Million - $2.66 Million	-91,040 Reduced 21.98%	323,075 $8.25 Million
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $3.24 Million - $6.66 Million	348,169 Added 527.96%	414,115 $7.64 Million
Q3 2017 Nov 14, 2017	BUY	$9.15 - $11.97 $603,405 - $789,373	65,946	65,946 $689,000

Others Institutions Holding COLL

# of Institutions

255

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account